Live Breaking News & Updates on Journal Of The Society For Neuro|Page 1

Stay updated with breaking news from Journal of the society for neuro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Enterome announces presentation of data from ongoing Phase 1/2 trial of its peptide-based immunotherapy EO2401 in recurrent glioblastoma (ROSALIE stud

Enterome announces presentation of data from ongoing Phase 1/2 trial of its peptide-based immunotherapy EO2401 in recurrent glioblastoma (ROSALIE study) at SNO 2022 EO2401 is a first-in-class OncoMimics™ peptide-based immunotherapy able to rapidly activate and significantly expand existing effector memory. ....

United States , Tampa Bay , France General , David Reardon , Journal Of The Society For Neuro , Professor Of Medicine At Harvard Medical School , Tampa Convention Center , Dana Farber Cancer Institute , Society For Neuro , Annual Meeting , Presentation Details , Harvard Medical School , Clinical Director , Dana Farber Cancer , Official Journal ,